Global /Japan /Healthcare /Biotechnology /177A
chevron_leftBack
Kohjin Bio Co., Ltd. logo

Kohjin Bio Co., Ltd.

177A
TSE: 177A Delayed
1,473JPY 3%
9.19 USD
As of 15 June 2026, Kohjin Bio Co., Ltd. has a market cap of $45.66M USD, ranking #31236 globally and #2930 in Japan. It ranks #2821 in the Healthcare sector, and #546 in the Biotechnology industry.
Global Rank
31236
Country Rank
2930
Sector Rank
2821
Industry Rank
546
Key Stats
Market Cap
$45.66MUSD
7.31B JPY
Enterprise Value
$43.4MUSD
6.95B JPY
Revenue (TTM)
$31.7MUSD
5.07B JPY
EBITDA (TTM)
$6.92MUSD
1.11B JPY
Net Income (TTM)
$3.48MUSD
557.0M JPY
EBITDA Margin
22%
Profit Margin
11%
PE Ratio
13.1
PS Ratio
1.4
PB Ratio
1.2
EV/EBITDA
6.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Takahito Nakamura open_in_new
Employees
167
Founded
1981
Website
kohjin-bio.jp open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
3% 5.1% 20% 9.6% -8.6% -18%

News

Loading...

Markets

Exchange Ticker Price
Tokyo Stock Exchange
MIC: XTKS
PRIMARY
177A
コージンバイオ株式会社
ISIN: JP3283630006
Shares Out.:
5.112M1 Shares Float: 1.605M2
TV:
SA:
YF:
GF:
BA:
MS:
1,473 JPY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Kohjin Bio Co., Ltd.

Kohjin Bio Co., Ltd. manufactures and sells of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics. The company offers tissue culture mediums for human cell culture, including human lymphocyte culture, hepatoblastoma-derived cell lines, adipose- derived stem cells, neural stem cells, fibroblast, vascular endothelial cells, and epidermal keratinocyte human cell cultures. It also provides industrial cell cultures for CHO, hybridomas, and insect cells; exosome production; cryopreservation solutions; cell dissociation agents; adoptCell-NK kits, and bag and other materials. In addition, the company offers microbial mediums for clinical microbiology culture mediums, microbiology culture medium for food and environment, antimicrobial resistance test kits, and staining kits for microbiology; immunochromatographic assay kit; I-block series; and human blood, serum, and plasma. Further, it engages in the production and sale of laboratory animal, sale of medical equipment, trust of animal immunization and antibody preparation, and import and export of products and raw materials. The company was formerly known as Kohjin Co.,Ltd and changed its name to Kohjin Bio Co., Ltd. in 1989. Kohjin Bio Co., Ltd. was incorporated in 1981 and is headquartered in Sakado, Japan.

Similar Companies

Industry: Biotechnology (Japan)
Name
Market Cap diff.
PE
2160
$1.02B
162.8B JPY
2K%
-
4587
$929.07M
148.73B JPY
2K%
-
$526.12M
84.22B JPY
1K%
-
4894
$349.74M
55.99B JPY
666%
-
504A
$169.88M
27.19B JPY
272%
-
$113.58M
18.18B JPY
149%
-
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
AMGN
$182.42B
399K%
23.9
GILD
$159.92B
350K%
19.0
ARGX
$47.84B
41.39B EUR
105K%
39.9
$44.84B
68.19T KRW
98K%
35.5
CSL
$42.36B
60.27B AUD
93K%
29.3
LONN
$42.3B
33.71B CHF
93K%
37.2
chevron_leftBack